Sartorius Stedim Biotech SA
PAR:DIM

Watchlist Manager
Sartorius Stedim Biotech SA Logo
Sartorius Stedim Biotech SA
PAR:DIM
Watchlist
Price: 184.3 EUR -0.81%
Market Cap: 17.9B EUR
Have any thoughts about
Sartorius Stedim Biotech SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Sartorius Stedim Biotech SA

Current Assets 1.7B
Cash & Short-Term Investments 475.3m
Receivables 363.3m
Other Current Assets 859m
Non-Current Assets 6.4B
Long-Term Investments 36.7m
PP&E 1.7B
Intangibles 4.6B
Other Non-Current Assets 61.4m
Current Liabilities 873.8m
Accounts Payable 203.2m
Accrued Liabilities 76.1m
Other Current Liabilities 594.5m
Non-Current Liabilities 3.3B
Long-Term Debt 2.8B
Other Non-Current Liabilities 540m

Balance Sheet
Sartorius Stedim Biotech SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
19
32
35
33
24
28
60
224
107
117
Cash Equivalents
19
32
35
33
24
28
60
224
107
117
Short-Term Investments
7
8
8
13
19
19
11
14
26
17
Total Receivables
134
152
205
236
233
232
263
371
419
334
Accounts Receivables
125
142
184
212
220
221
257
356
405
294
Other Receivables
9
10
21
24
13
11
6
15
14
40
Inventory
110
147
171
186
252
329
471
783
1 025
882
Other Current Assets
7
12
13
24
24
28
69
65
95
66
Total Current Assets
276
351
432
491
553
636
874
1 456
1 671
1 415
PP&E Net
192
223
261
331
436
550
644
928
1 292
1 633
PP&E Gross
192
223
261
331
436
550
644
928
1 292
1 633
Accumulated Depreciation
145
161
180
199
211
253
299
368
441
542
Intangible Assets
113
143
144
173
177
208
572
684
877
1 736
Goodwill
314
337
345
386
385
418
725
821
1 136
2 852
Long-Term Investments
1
1
2
12
6
14
13
15
25
41
Other Long-Term Assets
11
11
12
11
15
18
28
47
64
63
Other Assets
314
337
345
386
385
418
725
821
1 136
2 852
Total Assets
907
N/A
1 066
+18%
1 196
+12%
1 404
+17%
1 571
+12%
1 845
+17%
2 857
+55%
3 951
+38%
5 065
+28%
7 740
+53%
Liabilities
Accounts Payable
49
61
68
77
104
117
175
251
252
259
Accrued Liabilities
22
26
29
32
39
41
60
97
74
62
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
73
89
76
98
92
55
24
40
24
79
Other Current Liabilities
85
96
111
144
148
216
309
648
686
537
Total Current Liabilities
230
273
284
350
382
428
568
1 037
1 036
937
Long-Term Debt
33
30
26
62
58
84
563
585
1 112
3 603
Deferred Income Tax
28
30
29
43
39
45
85
126
178
400
Minority Interest
7
6
6
7
8
30
23
77
65
35
Other Liabilities
78
87
93
69
47
99
180
470
225
127
Total Liabilities
375
N/A
425
+13%
438
+3%
532
+21%
535
+1%
687
+28%
1 419
+107%
2 295
+62%
2 616
+14%
5 102
+95%
Equity
Common Stock
15
15
18
18
18
18
18
18
18
18
Retained Earnings
515
603
722
844
1 010
1 131
1 441
1 617
2 411
2 622
Other Equity
3
23
18
9
8
9
21
20
20
3
Total Equity
532
N/A
641
+20%
758
+18%
872
+15%
1 036
+19%
1 159
+12%
1 438
+24%
1 656
+15%
2 449
+48%
2 638
+8%
Total Liabilities & Equity
907
N/A
1 066
+18%
1 196
+12%
1 404
+17%
1 571
+12%
1 845
+17%
2 857
+55%
3 951
+38%
5 065
+28%
7 740
+53%
Shares Outstanding
Common Shares Outstanding
92
92
92
92
92
92
92
92
92
92

See Also

Discover More